This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Rebound Psychiatric and Physical Symptoms After Gabapentin Discontinuation

Gabriela Corá-Locatelli, Benjamin D. Greenberg, Juliet D. Martin, and Dennis L. Murphy

Published: March 15, 1998

Article Abstract

Sir: Serotonin reuptake inhibitors (SRIs) offer the most effective pharmacologic treatment for obsessive-compulsive disorder (OCD). Since few patients have a complete response, there is a compelling need for augmentation strategies. We initiated a pilot study to evaluate whether gabapentin might be a useful augmenting agent in a group of patients with OCD (Corá- Locatelli G, Greenberg BD, Martin JD, et al. 1997. Unpublished data).

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: Obsessive-Compulsive and Related Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...